These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10850573)

  • 21. Acute coagulopathy after reperfusion of the liver graft in children correction with recombinant activated factor VII.
    Markiewicz M; Kalicinski P; Kaminski A; Laniewski P; Ismail H; Drewniak T; Szymczak M; Nachulewicz P
    Transplant Proc; 2003 Sep; 35(6):2318-9. PubMed ID: 14529927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant activated factor VII for adjunctive hemorrhage control in trauma.
    Martinowitz U; Kenet G; Segal E; Luboshitz J; Lubetsky A; Ingerslev J; Lynn M
    J Trauma; 2001 Sep; 51(3):431-8; discussion 438-9. PubMed ID: 11535886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII.
    Moscardó F; Pérez F; de la Rubia J; Balerdi B; Lorenzo JI; Senent ML; Aznar I; Carceller S; Sanz MA
    Br J Haematol; 2001 Jul; 114(1):174-6. PubMed ID: 11472364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Using recombinant activated blood coagulation factor VII for treatment of hemorrhagic syndrome in patients with thrombocytopenia].
    Galstian GM; Kolosova IV
    Anesteziol Reanimatol; 2014; 59(6):60-6. PubMed ID: 25831706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
    Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage.
    Nohira T; Osakabe Y; Suda S; Takahashi C; Tanaka A; Ikeda K; Ikeda T; Okabe K
    J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):623-30. PubMed ID: 18840167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant factor VIIa improves coagulopathy caused by liver failure.
    Brown JB; Emerick KM; Brown DL; Whitington PF; Alonso EM
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):268-72. PubMed ID: 12960648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients.
    Schmid P; Mordasini A; Luginbühl M; Regli B; Kohler HP; Zimmermann H; Inderbitzin D; Hirt A; Lämmle B; Alberio L
    Swiss Med Wkly; 2011; 141():w13213. PubMed ID: 21735365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of coagulopathy with recombinant factor VIIa in a neonate with echovirus type 7.
    Tancabelic J; Haun SE
    Pediatr Blood Cancer; 2004 Aug; 43(2):170-6. PubMed ID: 15236286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.
    Mariani G; Napolitano M; Dolce A; Pérez Garrido R; Batorova A; Karimi M; Platokouki H; Auerswald G; Bertrand AM; Di Minno G; Schved JF; Bjerre J; Ingerslev J; Sørensen B; Ruiz-Saez A; ;
    Thromb Haemost; 2013 Feb; 109(2):238-47. PubMed ID: 23238632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitors.
    Smith OP
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():22-5. PubMed ID: 12214142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery.
    Al Douri M; Shafi T; Al Khudairi D; Al Bokhari E; Black L; Akinwale N; Osman Musa M; Al Homaidhi A; Al Fagih M; Borum Andreasen R
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S121-7. PubMed ID: 10850577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboelastometry identifies coagulopathy associated with liver failure and disseminated intravascular coagulation caused by yellow fever, guiding specific hemostatic therapy: a case report.
    Crochemore T; Savioli FA; Guerra JCC; Kalmar EMDN
    Rev Bras Ter Intensiva; 2020; 32(3):474-478. PubMed ID: 33053039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low plasma FVII:C and activated FVII as predictive markers for overt disseminated intravascular coagulation.
    Lertthammakiat S; Anantasit N; Anurathapan U; Sirachainan N; Kadegasem P; Chuansumrit A
    Thromb Haemost; 2017 Jul; 117(8):1471-1477. PubMed ID: 28492702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of life-threatening hemorrhages and unsafe interventions in nonhemophiliac children by recombinant factor VIIa.
    Leblebisatan G; Sasmaz I; Antmen B; Yildizdas D; Kilinc Y
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):77-82. PubMed ID: 18838398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgery in patients with congenital factor VII deficiency - a single center study.
    Szczepanik A; Wiszniewski A; Oses-Szczepanik A; Dąbrowski W; Pielaciński K; Misiak A
    Pol Przegl Chir; 2018 May; 90(5):1-5. PubMed ID: 30426948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NovoSeven (recombinant factor VIIa) in centeral nervous systems bleeds.
    Rice KM; Savidge GF
    Haemostasis; 1996; 26 Suppl 1():131-4. PubMed ID: 8904187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy.
    Schmid S; Friesenecker B; Lorenz I; Innerhofer P; Koscielny J; Velik-Salchner C; Mutz N; Fries D
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):313-7. PubMed ID: 17636194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.